益腎泄?jié)岱街委熗达L(fēng)性腎病并慢性腎衰竭32例中醫(yī)英語論文

1、益腎泄?jié)岱街委熗达L(fēng)性腎病并慢性腎衰益腎泄?jié)岱街委熗达L(fēng)性腎病并慢性腎衰竭3232例ClinicalEfficacyofYishenXiezhuoDecoctioninTreatingGoutyNephropathyComplicatingChronicRenalFailurein32Cases目的觀察益腎泄?jié)岱街委熗达L(fēng)性腎病并慢性腎衰竭的療效。方法將64例痛風(fēng)性腎病并慢性腎衰竭患者隨機(jī)分為研究組和對照組各32例。研究組患者采用益腎泄?jié)岱街?/p>

2、療對照組采用常規(guī)西藥治療比較兩組患者的臨床療效及不良反應(yīng)。結(jié)果研究組的總有效率為84.37%明顯高于對照組的68.75%（χ^2=4.11P〈0.05）治療后研究組的血尿酸、血尿素氮、血肌酐、肌酐清除率等指標(biāo)與對照組比較有明顯差異（t=4.653.255.013.97P〈0.05）兩組患者不良反應(yīng)發(fā)生率比較無明顯差異。結(jié)論益腎泄?jié)岱街委熗达L(fēng)性腎病并慢性腎衰竭的療效確切不良反應(yīng)發(fā)生率低值得臨床推廣。ObjectiveToinvestiga

3、tetheclinicaleffectofYishenXiezhuoDecoctionintreatinggoutynephropathycomplicatingchronicrenalfailureMethods64patientswithgoutynephropathycomplicatingchronicrenalfailurewereromlydividedintothestudygroupthecontrolgroup32ca

4、sesineachgroup.ThestudygroupadoptedYishenXiezhuoDecoctionwhilethecontrolgroupwasgiventheroutinewesternmedicinetherapy.TheclinicaleffectadversereactionswerecomparedDetueenthetwogroups.ResultsThetotaleffectiveratewas84.37%

5、inthestudygroupwhichwassignificantlyhigherthan68.75%inthecontrolgroup（χ^2=4.11P〈0.05）theindexesofblooduricacidbloodureanitrogenserumcreatininecreatinineclearancerateaftertreatmentinthestudygrouphadstatisticallysignifican

6、tdifferencescomparedwiththecontrolgroup（t=4.653.255.013.97P〈0.05）.Theoccurrencerateofadversereactionshadnosignificantdifferencebetweenthetwogroups.ConclusionYishenXiezhuoDecoctionhasthedefiniteclinicaleffectintreatinggou

7、tynephropathycomplicatingchronicrenalfailurelowoccurrencerateofadversereactionswhichiswthyofclinicalpromotion.小劑量初次腹膜透析對慢性腎衰竭患者小劑量初次腹膜透析對慢性腎衰竭患者殘余腎功的影響殘余腎功的影響Theinfluenceoflowdoseprimaryperitonealdialysisonresidualrenalf

8、unctionofpatientswithchronicrenalfailure目的探討小劑量腹膜透慢性腎功能患者殘余腎功能的影響。方法將80例慢性腎功能衰竭的患者按照初次腹膜透析用藥劑量的不同分為A組和B組，A組采用的透析劑量renalfailure（CRF）modeltoexpleitsmechanism.Methods：ThemodelofCRFinratswereestablishedbythemethodof56nephrec

9、tomy.RatswereromlydividedintocontrolgroupmodelcontrolgrouphighChaibanliuhedecoctiongrouplowChaibanliuhedecoctiongroupNiaoduqingcontrolgroup.ThelevelsofScrBUNGASMTLSSinserumweredetectedthepathologicalchangesofGastricmucos

10、awereobservedbyhematoxylineosin（HE）staining.Results：ComparedwithmodelcontrolgroupScrBUNGASMTLdecreasedwhileSSincreasedsignificantlyineveryadministrationgroup.ThelevelsofScrBUNGASMTLinthehighChaibanliuhedecoctiongroupwere

11、lowerthanthatinthelowChaibanliuhedecoctiongroupNiaoduqingcontrolgroupwhilethelevelofSSwashigher.ComparedwiththatintheNiaoduqingcontrolgroupGASMTLdecreasedwhileSSincreasedinthelowChaibanliuhedecoctiongroup.Therewasnosigni

12、ficantdifferencebetweenlowChaibanliuhedecoctiongroupNiaoduqingcontrolgroupwiththelevelsofScrBUN.Conclusion：ChaibanliuhedecoctioncanimprovethegastrointestinalsymptomsofCRFinratmodelbydecreasingthelevelsofGASMTLincreasingt